It is used as endocrine therapy in women with ER/PR-positive stage 4 or recurrent metastatic breast cancer and has demonstrated similar efficacy compared to TAM in the treatment of metastatic breast cancer and as adjuvant breast cancer therapy.
It is used as endocrine therapy in women with ER/PR-positive stage 4 or recurrent metastatic breast cancer. And has demonstrated similar efficacy compared to TAM in the treatment of metastatic breast cancer and as adjuvant breast cancer therapy.